Trinity Delta’s business is institutional quality issuer-paid equity research.

Our company coverage and past research notes can be accessed via the dedicated Company Pages below, or from our Research Library.

BerGenBio
BerGenBio is a clinical-stage, drug development company based in Bergen, Norway and Oxford, UK. It is developing innovative anti-cancer therapies that act on the promising Axl signalling pathway.
Read more
Bonesupport
Bonesupport is a Swedish orthobiologics company with a pipeline of unique injectable drug-eluting, bioceramic bone graft substitutes based on its proprietary CERAMENT technology.
Read more
e­-therapeutics
e­-therapeutics is a drug discovery company with a proprietary network­-driven drug discovery platform, which using artificial intelligence (AI), machine learning and other computational techniques.
Read more
Hutchison China MediTech
Hutchison China MediTech, a Hong Kong-based biopharmaceutical company, developing and commercialising innovative, highly selective oral tyrosine kinase inhibitor therapies for oncology and immunological indications.
Read more
Kind Consumer
Kind Consumer has developed a novel nicotine delivery device, Voke, that mimics the important aspects of cigarette smoking.
Read more
MaxCyte
MaxCyte has a patented flow electroporation platform for the transfection of a wide array of cells, and has a proprietary mRNA-mediated CAR technology, known as CARMA.
Read more
Mereo BioPharma
Mereo BioPharma develops and commercialises innovative therapeutics addressing rare and specialty diseases. These are acquired or licensed in at clinical stages from large pharmaceutical companies.
Read more
Nexstim
Nexstim is a targeted neuro-modulation company that has developed a proprietary navigated rTMS platform for use in diagnostics (NBS) and therapeutics (NBT).
Read more
Scancell
Scancell is a clinical-stage immuno-oncology specialist that is developing two innovative and flexible therapeutic vaccine platforms, ImmunoBody and Moditope.
Read more
Tissue Regenix Group
Tissue Regenix is a regenerative medicine company with a portfolio of soft tissue and bone products and two proprietary platform, dCELL, and BioRinse.
Read more

Subscribe to our research

Please sign up here to be added to our distribution database.